BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 112 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $714,000 | -14.0% | 230,202 | +0.1% | 0.00% | 0.0% |
Q3 2021 | $830,000 | +3.0% | 230,015 | +2.2% | 0.00% | 0.0% |
Q2 2021 | $806,000 | +75.2% | 225,074 | +91.5% | 0.00% | +33.3% |
Q1 2021 | $460,000 | +1816.7% | 117,535 | +1930.3% | 0.00% | – |
Q4 2020 | $24,000 | +14.3% | 5,789 | +4.3% | 0.00% | – |
Q3 2020 | $21,000 | -93.6% | 5,549 | -92.7% | 0.00% | -100.0% |
Q2 2020 | $330,000 | -66.2% | 75,718 | -70.6% | 0.00% | -71.4% |
Q1 2020 | $977,000 | -60.7% | 257,871 | -34.5% | 0.01% | -36.4% |
Q4 2019 | $2,488,000 | +41.7% | 393,609 | -27.6% | 0.01% | +22.2% |
Q1 2016 | $1,756,000 | +74.2% | 543,649 | +158.5% | 0.01% | +80.0% |
Q4 2015 | $1,008,000 | +13.9% | 210,336 | +32.2% | 0.01% | 0.0% |
Q3 2015 | $885,000 | +201.0% | 159,084 | +331.3% | 0.01% | +400.0% |
Q2 2015 | $294,000 | -68.9% | 36,886 | -33.4% | 0.00% | -80.0% |
Q3 2014 | $946,000 | +2.2% | 55,343 | -27.9% | 0.01% | +25.0% |
Q2 2014 | $926,000 | +1029.3% | 76,722 | +278.3% | 0.00% | – |
Q2 2013 | $82,000 | – | 20,280 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 2,000,000 | $7,820,000 | 6.23% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $37,262,000 | 0.78% |
EMC Capital Management | 193,906 | $758,000 | 0.54% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,486,454 | $13,632,000 | 0.50% |
ALGERT GLOBAL LLC | 344,210 | $1,346,000 | 0.43% |
Hillsdale Investment Management Inc. | 877,000 | $3,430,000 | 0.29% |
Stanley-Laman Group, Ltd. | 349,465 | $1,366,000 | 0.22% |
SHEPHERD KAPLAN KROCHUK, LLC | 94,000 | $368,000 | 0.14% |
GLOBEFLEX CAPITAL L P | 178,474 | $698,000 | 0.13% |
Zebra Capital Management LLC | 23,622 | $92,000 | 0.10% |